Grant RM - Search Results

1

Effectiveness and safety of oral HIV preexposure prophylaxis for all populations.

Fonner VA, Dalglish SL, Kennedy CE, Baggaley R, O'Reilly KR, Koechlin FM, Rodolph M, Hodges-Mameletzis I, Grant RM. Fonner VA, et al. Among authors: grant rm. AIDS. 2016 Jul 31;30(12):1973-83. doi: 10.1097/QAD.0000000000001145. AIDS. 2016. PMID: 27149090 Free PMC article. Review.

2

Not all is dead in HIV-1 graveyard.

Grant RM, Abrams DI. Grant RM, et al. Lancet. 1998 Jan 31;351(9099):308-9. doi: 10.1016/S0140-6736(05)78343-4. Lancet. 1998. PMID: 9652607 No abstract available.

3

Activity of a ritonavir plus saquinavir-containing regimen in patients with virologic evidence of indinavir or ritonavir failure.

Deeks SG, Grant RM, Beatty GW, Horton C, Detmer J, Eastman S. Deeks SG, et al. Among authors: grant rm. AIDS. 1998 Jul 9;12(10):F97-102. doi: 10.1097/00002030-199810000-00002. AIDS. 1998. PMID: 9677159

4

Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection.

Staprans S, Marlowe N, Glidden D, Novakovic-Agopian T, Grant RM, Heyes M, Aweeka F, Deeks S, Price RW. Staprans S, et al. Among authors: grant rm. AIDS. 1999 Jun 18;13(9):1051-61. doi: 10.1097/00002030-199906180-00008. AIDS. 1999. PMID: 10397535

5

Loss of antiretroviral drug susceptibility at low viral load during early virological failure in treatment-experienced patients.

Parkin NT, Deeks SG, Wrin MT, Yap J, Grant RM, Lee KH, Heeren D, Hellmanna NS, Petropoulos CJ. Parkin NT, et al. Among authors: grant rm. AIDS. 2000 Dec 22;14(18):2877-87. doi: 10.1097/00002030-200012220-00009. AIDS. 2000. PMID: 11153669 Clinical Trial.

6

Cerebrospinal fluid response to structured treatment interruption after virological failure.

Price RW, Paxinos EE, Grant RM, Drews B, Nilsson A, Hoh R, Hellmann NS, Petropoulos CJ, Deeks SG. Price RW, et al. Among authors: grant rm. AIDS. 2001 Jul 6;15(10):1251-9. doi: 10.1097/00002030-200107060-00006. AIDS. 2001. PMID: 11426069

7

Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormone.

Napolitano LA, Lo JC, Gotway MB, Mulligan K, Barbour JD, Schmidt D, Grant RM, Halvorsen RA, Schambelan M, McCune JM. Napolitano LA, et al. Among authors: grant rm. AIDS. 2002 May 24;16(8):1103-11. doi: 10.1097/00002030-200205240-00003. AIDS. 2002. PMID: 12004268 Clinical Trial.

8

Emergence of drug-resistant HIV-1 variants in patients undergoing structured treatment interruptions.

Schweighardt B, Ortiz GM, Grant RM, Wellons M, Miralles GD, Kostrikis LG, Bartlett JA, Nixon DF. Schweighardt B, et al. Among authors: grant rm. AIDS. 2002 Nov 22;16(17):2342-4. doi: 10.1097/00002030-200211220-00018. AIDS. 2002. PMID: 12441810

9

Persistence of drug-resistant HIV-1 after a structured treatment interruption and its impact on treatment response.

Deeks SG, Grant RM, Wrin T, Paxinos EE, Liegler T, Hoh R, Martin JN, Petropoulos CJ. Deeks SG, et al. Among authors: grant rm. AIDS. 2003 Feb 14;17(3):361-70. doi: 10.1097/00002030-200302140-00010. AIDS. 2003. PMID: 12556690

10

High levels of adherence do not prevent accumulation of HIV drug resistance mutations.

Bangsberg DR, Charlebois ED, Grant RM, Holodniy M, Deeks SG, Perry S, Conroy KN, Clark R, Guzman D, Zolopa A, Moss A. Bangsberg DR, et al. Among authors: grant rm. AIDS. 2003 Sep 5;17(13):1925-32. doi: 10.1097/00002030-200309050-00011. AIDS. 2003. PMID: 12960825

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters